Pharmadule AB Strengthens Its Presence in the Chinese Market; Alliance With Morimatsu Group

STOCKHOLM--(BUSINESS WIRE)--Pharmadule, the world leader in high-tech modular facilities for the pharmaceutical and biopharmaceutical industries today announced a partner agreement with Morimatsu Group. The agreement will give Morimatsu rights of manufacturing modules together with Pharmadule for the Chinese market. The cooperation supplements Pharmadule’s main production facility in Tallinn, Estonia.

MORE ON THIS TOPIC